The landscape of genetic medicines for in vivo T cell reprogramming
{{output}}
In vivo reprogramming of T cells represents a transformative approach in immune-based therapies, with the potential to overcome the limitations of traditional ex vivo-engineered T cell products, such as autologous CAR-T therapies. While CAR-T cells have achiev... ...
